Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
822.93B | 815.27B | 710.94B | 631.81B | 637.26B | Gross Profit |
355.34B | 319.59B | 307.32B | 286.60B | 282.27B | EBIT |
75.58B | 55.38B | 85.50B | 42.73B | 67.33B | EBITDA |
101.25B | 103.33B | 123.38B | 117.18B | 107.59B | Net Income Common Stockholders |
31.64B | 39.08B | 61.03B | 24.52B | 49.57B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
166.15B | 129.91B | 179.33B | 199.39B | 179.70B | Total Assets |
896.11B | 850.49B | 811.15B | 743.90B | 731.47B | Total Debt |
37.71B | 37.42B | 40.83B | 57.46B | 107.01B | Net Debt |
-128.44B | -81.62B | -127.09B | -133.54B | -61.41B | Total Liabilities |
227.99B | 253.81B | 249.94B | 244.19B | 286.30B | Stockholders Equity |
668.05B | 596.62B | 561.15B | 483.05B | 428.52B |
Cash Flow | Free Cash Flow | |||
93.54B | -28.05B | 36.41B | 81.75B | 61.66B | Operating Cash Flow |
141.03B | 14.43B | 72.25B | 109.27B | 87.75B | Investing Cash Flow |
-42.07B | -32.20B | -40.78B | -25.08B | -27.95B | Financing Cash Flow |
-61.58B | -36.64B | -65.19B | -74.04B | -14.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $22.80T | 19.98 | 14.40% | 0.52% | 9.56% | 26.52% | |
77 Outperform | ¥16.77T | 27.44 | 10.50% | 1.06% | 0.56% | 5.32% | |
73 Outperform | ¥5.80T | 26.08 | 11.70% | 0.85% | -5.48% | -11.96% | |
72 Outperform | ¥4.38T | 25.34 | 3.42% | 9.08% | -33.61% | ||
71 Outperform | ¥940.63B | 9.80 | 25.48% | 2.77% | 30.34% | 55.11% | |
64 Neutral | $4.27B | 11.80 | 5.31% | 249.79% | 4.07% | -9.02% | |
63 Neutral | ¥645.86B | 18.23 | 5.01% | 3.58% | 6.67% | -17.06% |